본문으로 건너뛰기
← 뒤로

Correction: NK-92 cells labeled with FeO-PEG-CD56/Avastin@Ce6 nanoprobes for the targeted treatment and noninvasive therapeutic evaluation of breast cancer.

1/5 보강
Journal of nanobiotechnology 📖 저널 OA 92% 2021: 1/1 OA 2023: 2/2 OA 2024: 5/5 OA 2025: 57/57 OA 2026: 84/97 OA 2021~2026 2026 Vol.24(1) OA Nanoparticle-Based Drug Delivery
Retraction 확인
출처
PubMed DOI PMC OpenAlex 마지막 보강 2026-04-30
OpenAlex 토픽 · Nanoparticle-Based Drug Delivery Cancer Cells and Metastasis Nanoplatforms for cancer theranostics

Lian J, Li M, Duan M, Sun X, Wang Z, Guo X, Li J, Gao G, Li K

이 논문을 인용하기

↓ .bib ↓ .ris
APA Jingge Lian, Meng Li, et al. (2026). Correction: NK-92 cells labeled with FeO-PEG-CD56/Avastin@Ce6 nanoprobes for the targeted treatment and noninvasive therapeutic evaluation of breast cancer.. Journal of nanobiotechnology, 24(1). https://doi.org/10.1186/s12951-026-04332-2
MLA Jingge Lian, et al.. "Correction: NK-92 cells labeled with FeO-PEG-CD56/Avastin@Ce6 nanoprobes for the targeted treatment and noninvasive therapeutic evaluation of breast cancer.." Journal of nanobiotechnology, vol. 24, no. 1, 2026.
PMID 41963970 ↗

같은 제1저자의 인용 많은 논문 (2)

📖 전문 본문 읽기 PMC JATS · ~3 KB · 영문
Correction: Journal of Nanobiotechnology (2024)
22: 313

10.1186/s12951-024-02599-x

The author regret an error in the presentation of images in the original publication. In Fig. 7G, the H&E staining image of liver in the PBS group was mistakenly used and was an inadvertent duplication of liver image in NK + NPs+L group. This error occurred due to a mistake during the data organization and figure assembly. The authors declare that this correction does not affect the validity of the original discussion, interpretation, and conclusion presented in this paper. For completeness and transparency, the old incorrect and correct versions are displayed below.
Incorrect Fig. 7.

Correct Fig. 7.

The original article has been corrected.

출처: PubMed Central (JATS). 라이선스는 원 publisher 정책을 따릅니다 — 인용 시 원문을 표기해 주세요.

🟢 PMC 전문 열기